Reperfusion synergism: will it be both sustained and safe?
Publication
, Journal Article
Armstrong, PW
Published in: Eur Heart J
December 2000
Duke Scholars
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
December 2000
Volume
21
Issue
23
Start / End Page
1913 / 1916
Location
England
Related Subject Headings
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Humans
- Fibrinolytic Agents
- Drug Synergism
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W. (2000). Reperfusion synergism: will it be both sustained and safe? Eur Heart J, 21(23), 1913–1916. https://doi.org/10.1053/euhj.2000.2432
Armstrong, P. W. “Reperfusion synergism: will it be both sustained and safe?” Eur Heart J 21, no. 23 (December 2000): 1913–16. https://doi.org/10.1053/euhj.2000.2432.
Armstrong PW. Reperfusion synergism: will it be both sustained and safe? Eur Heart J. 2000 Dec;21(23):1913–6.
Armstrong, P. W. “Reperfusion synergism: will it be both sustained and safe?” Eur Heart J, vol. 21, no. 23, Dec. 2000, pp. 1913–16. Pubmed, doi:10.1053/euhj.2000.2432.
Armstrong PW. Reperfusion synergism: will it be both sustained and safe? Eur Heart J. 2000 Dec;21(23):1913–1916.
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
December 2000
Volume
21
Issue
23
Start / End Page
1913 / 1916
Location
England
Related Subject Headings
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Humans
- Fibrinolytic Agents
- Drug Synergism
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences